The next big thing in medical science: POO TRANSPLANTS

Your brother's gonna die, kid, unless we can give him your, well ...


Oral fecal delivery mechanism (belp)

Gut dysbiosis (unbalanced or skewed bacterial ecology) is associated with more than obesity, it appears to have a role in a range of other conditions: metabolic syndrome, type II diabetes, inflammatory bowel disease, Crohn’s disease, colorectal cancer, irritable bowel syndrome. It’s also being investigated in depression, rheumatoid arthritis, asthma and … well, you get the picture.

There are some, like Susannah Salter and Alan Walker of the Wellcome Trust Sanger Institute, who are openly wondering whether some of these results are down to bacterial contamination of lab kit. This is possible in some cases but it is also becoming clear that there’s something significant we’re learning about ourselves.

Now, what about the yuck factor? While all of this is very interesting in an academic kind of way, it starts to get interesting, and messy, when we look at what we can do clinically with this new knowledge. It happens that one of the simplest ways to transfer the effects of the “good bacteria” is to just transfer the bacteria from one individual to another.

Welcome to the world of the fecal transplant.

If we go back to our mousey models of cancer, scientists have transplanted poo from the mice with the “good bacteria” into mice without and have found that the immune defences against cancer have been boosted. Same for mice with a tendency to obesity – a poo transfer into tubby mice fed a “fast food” diet has seen them continue on the same diet and not put on the pounds (OK, grams – they don’t ever get that big).

Multiple experimental models have shown the same thing in multiple health conditions – fecal transplants are an effective mechanism for transferring entire ecosystems of good bacteria and with them the positive effects they engender.

And it’s more than mouse models. Poo transplants (more politely known as fecal microbiota transplants) have also been tried, successfully, in people. The process is not for the squeamish. Basically it consists of finding a healthy donor (often a relative or partner), screening for diseases and the presence of pathogens in the stool and then taking a fresh stool sample. This is processed, normally turned into a solution with saline, and then infused into the recipient (usually via enema).

One approach has been to use frozen poop – it’s easier to deal with and appears to be as medically efficacious. Ideally of course doctors and patients would rather not have to deal with fecal material at all.

It’s not nice, but the process has been used successfully to treat people with life-threatening C. Difficile infections. Positive results have also been reported in severe Crohn’s disease, ulcerative colitis and other inflammatory bowel conditions, even in cases that have been resistant to all of the standard treatments.

Some of the results have been so positive that desperate patients who have been unable to get access to a clinical trial or treatment at a hospital have opted to go the DIY route. In fact there’s a whole subculture emerging of patients who are doing this at home as a way of alleviating a wide variety of medical conditions. Obviously the DIY approach is fairly low tech but it does appear to work in many cases. As you would expect, this is really a last resort and is not recommended by us here on the Reg medical desk.

From DIY to over-the-counter

Of course the positive results that have been reported in small clinical trials and by doctors have spurred on efforts to come up with a mechanism a bit less vile and smelly. One approach has been to use frozen poop – it’s easier to deal with and appears to be as medically efficacious. Ideally, of course, doctors and patients would rather not have to deal with fecal material at all. To that end the race is on to come up with capsules that contain the right mix of bacteria and give the same outcome.

There are already plenty of probiotic tablets and capsules on sale in pharmacies and health food shops, but these tend to be limited to one or two specific species of bacteria (usually varieties of lactobacilli or bifidobacteria, the sort of bacteria you’ll find in live yoghurt). In practice these don’t have the same effect as the complex mix of bacterial populations that are found in the gut, hence the research efforts to come up with the right combination for a pill to replace the poop.

It’s relatively early days in all of this, but I for one fully expect to see more use of bacterial transplants (whether by pill or raw material) in additional medical indications. It may well be that the day will come when we treat colorectal cancer patients with bacteria as well as drugs, and when the clinically obese take full spectrum probiotics as well as changing their diets.

In the meantime just having the occasional live yoghurt or trendy lactofermented juice could well be worth doing. ®

Similar topics


Other stories you might like

  • Photonic processor can classify millions of images faster than you can blink
    We ask again: Has science gone too far?

    Engineers at the University of Pennsylvania say they've developed a photonic deep neural network processor capable of analyzing billions of images every second with high accuracy using the power of light.

    It might sound like science fiction or some optical engineer's fever dream, but that's exactly what researchers at the American university's School of Engineering and Applied Sciences claim to have done in an article published in the journal Nature earlier this month.

    The standalone light-driven chip – this isn't another PCIe accelerator or coprocessor – handles data by simulating brain neurons that have been trained to recognize specific patterns. This is useful for a variety of applications including object detection, facial recognition, and audio transcription to name just a few.

    Continue reading
  • World’s smallest remote-controlled robots are smaller than a flea
    So small, you can't feel it crawl

    Video Robot boffins have revealed they've created a half-millimeter wide remote-controlled walking robot that resembles a crab, and hope it will one day perform tasks in tiny crevices.

    In a paper published in the journal Science Robotics , the boffins said they had in mind applications like minimally invasive surgery or manipulation of cells or tissue in biological research.

    With a round tick-like body and 10 protruding legs, the smaller-than-a-flea robot crab can bend, twist, crawl, walk, turn and even jump. The machines can move at an average speed of half their body length per second - a huge challenge at such a small scale, said the boffins.

    Continue reading
  • Intel: Our fabs can mass produce silicon qubit devices
    If conventional silicon manufacturing processes can be repurposed, it could help create practical quantum systems

    Updated Intel and QuTech claim to have created the first silicon qubits for quantum logic gates to be made using the same manufacturing facilities that Intel employs to mass produce its processor chips.

    The demonstration is described by the pair as a crucial step towards scaling to the thousands of qubits that are required for practical quantum computation.

    According to Intel, its engineers working with scientists from QuTech have successfully created the first silicon qubits at scale at Intel's D1 manufacturing factory in Hillsboro, Oregon, using a 300mm wafer similar to those the company uses to mass produce processor chips.

    Continue reading
  • TACC Frontera's 2022: Academic supercomputer to run intriguing experiments
    Plus: Director reveals 10 million node hours, 50-70 million core hours went into COVID-19 research

    The largest academic supercomputer in the world has a busy year ahead of it, with researchers from 45 institutions across 22 states being awarded time for its coming operational run.

    Frontera, which resides at the University of Texas at Austin's Texas Advanced Computing Center (TACC), said it has allocated time for 58 experiments through its Large Resource Allocation Committee (LRAC), which handles the largest proposals. To qualify for an LRAC grant, proposals must be able to justify effective use of a minimum of 250,000 node hours and show that they wouldn't be able to do the research otherwise. 

    Two additional grant types are available for smaller projects as well, but LRAC projects utilize the majority of Frontera's nodes: An estimated 83% of Frontera's 2022-23 workload will be LRAC projects. 

    Continue reading

Biting the hand that feeds IT © 1998–2022